Medication guide · Updated 2026
GLP-1 receptor agonist used for weight loss and type-2 diabetes. Available as compounded formulations and FDA-approved branded versions.
Generic name
Semaglutide
Drug class
glp1
Brand names
Wegovy, Ozempic
Telehealth offering
0 brands
Semaglutide mimics GLP-1, a hormone the gut releases after eating. It slows gastric emptying, reduces appetite signals to the brain, and improves insulin response — leading to gradual weight loss and better glycemic control.
4 variants of Compounded Semaglutide.
| Strength | Form | Price range / month | Notes |
|---|---|---|---|
| 0.25 mg/week | subcutaneous injection | — | — |
| 0.5 mg/week | subcutaneous injection | — | — |
| 1.0 mg/week | subcutaneous injection | — | — |
| 2.4 mg/week | subcutaneous injection | — | — |
Average cash-pay cost: $250/mo
Standard titration for Compounded Semaglutide. Provider may adjust based on tolerance.
| Weeks | Dose | Purpose |
|---|---|---|
| 1–4 | 0.25 mg weekly | Initiation — GI tolerance |
| 5–8 | 0.5 mg weekly | First therapeutic dose |
| 9–12 | 1.0 mg weekly | Effective range start |
| 13–16 | 1.7 mg weekly | Mid-titration |
| 17+ | 2.4 mg weekly | Maintenance / max dose |
Reference schedule. Final titration always determined by prescribing clinician.
Educational reference only. Not medical advice. Verify dose, indications, and interactions with a licensed prescriber.
Compounded Semaglutide (generic: Semaglutide) is a GLP-1 receptor agonist that modulates appetite and metabolism by mimicking the gut hormone glucagon-like peptide-1. Available branded formulations include Wegovy and Ozempic. Both FDA-approved and compounded formulations are available; compounded versions are typically lower cost but vary in quality control between 503A pharmacies.
Compounded Semaglutide is typically prescribed for patients with type 2 diabetes (FDA indication) or, off-label, adults with BMI ≥30 (or ≥27 with comorbidity) for weight management. Increasingly used in women managing PCOS-related insulin resistance. As with all prescription medications, suitability is determined by a licensed clinician based on individual medical history, current medications, and treatment goals.
Typical strengths include 0.25 mg/week, 0.5 mg/week, 1.0 mg/week, and 2.4 mg/week.
Before starting Compounded Semaglutide, ask your prescribing clinician about: your full medication and supplement list (for interaction screening), recent labs that are relevant to the medication's mechanism, monitoring cadence after starting, and what specific outcome they expect to see in the first 4–12 weeks. Common side effects to watch for include , , , and undefined, among others. Most are dose-dependent and improve with time or dose adjustment.
GLP-1 receptor agonist used for weight loss and type-2 diabetes. Available as compounded formulations and FDA-approved branded versions.
Compounded Semaglutide is administered glp1. Doses depend on indication and patient response. See the brand pages above for program-specific dosing.
Coverage varies wildly by plan tier and indication. Many GLP-1 + HRT medications require prior authorization. Some compounded versions are not insurance-billable. See individual brand pages for coverage status.
Most common: , , . See full list above. Always report new symptoms to your provider.
Drug-drug interactions matter — especially for HRT + thyroid + GLP-1 combinations. Use our drug interaction checker, and always disclose your full medication list to the prescriber.
Take the matcher quiz to filter providers by medication availability, insurance, and location.